XenoPort, Inc.
Overview
XenoPort, Inc. is a biopharmaceutical company focused on the development of innovative therapies for the treatment of neurological disorders. It operates as a subsidiary of Arbor Pharmaceuticals, LLC.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to XenoPort, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.